Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.

@article{Toth2009DrugTF,
  title={Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.},
  author={Peter P. Toth and Thomas D. Dayspring and Gregory S Pokrywka},
  journal={Current atherosclerosis reports},
  year={2009},
  volume={11 1},
  pages={71-9}
}
The reduction of low-density lipoprotein cholesterol in patients at risk for acute cardiovascular events is the cornerstone of lipid management in both the primary and secondary prevention settings. Serum triglyceride levels exceeding 150 mg/dL are abnormal and confer increased risk for developing coronary artery disease in both men and women. Serum triglycerides are derived from both dietary and endogenous biosynthetic pathways. Triglyceride metabolism has a complex regulatory circuitry and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…